Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00IZD
|
|||
| Former ID |
DIB014323
|
|||
| Drug Name |
DVC1-0101
|
|||
| Synonyms |
Ischemia gene therapy, DNAVEC\Kyushu University; FGF2-carrying Sendai virus, DNAVEC\Kyushu University; SeV-FGF2 gene therapy (virus recombinant, ischaemia) DNAVEC\Kyushu University
Click to Show/Hide
|
|||
| Indication | Arteriosclerosis [ICD-11: BD40; ICD-9: 440] | Phase 2 | [1] | |
| Company |
DNAVEC Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial. Mol Ther. 2013 Mar;21(3):707-14. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.